Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance

Clinical trial NCT06856291 · RECRUITING

Trial details

NCT number: NCT06856291
Sponsor: ETH Zurich
Status: RECRUITING
Study type: OBSERVATIONAL

Obesity and Obesity-related Medical Conditions Obesity and Overweight Insulin Sensitivity/Resistance Semaglutide

Start date: 2025-03-15
Primary completion: 2026-08-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.